Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Aug;275(5):1359-1371.
doi: 10.1007/s00406-024-01920-x. Epub 2024 Oct 9.

Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis

Jiafeng Li et al. Eur Arch Psychiatry Clin Neurosci. 2025 Aug.

Abstract

The current systematic review and meta-analysis examined the effect of racemic ketamine or esketamine on suicidal ideation in individuals with uni- or bipolar depression. We searched the MEDLINE, Embase, Central, PsycINFO, and Web of Science databases to identify randomized controlled trials that examined the effect of racemic ketamine or esketamine monotherapy on suicidal ideation (SI) in individuals with uni- or bipolar depression. The two monotherapies were compared; the primary outcome was the rate of remission of SI, and the secondary outcome was the SI score. The risk ratio was used as an effect size measure for binary variables, while the standardized mean difference was used as an effect size measure for continuous variables. Our meta-analysis included 13 randomized controlled trials involving 1,1109 individuals with uni- or bipolar depression. Patients receiving racemic ketamine monotherapy had a significantly higher acute SI remission rate than those receiving placebo or midazolam (RR = 2.06, 95% CI 1.47 to 2.91, P < 0.0001). Racemic ketamine also led to significantly lower SI scores than placebo or midazolam (SMD = -0.36, 95% CI -0.71 to -0.01, P = 0.04). The evidence for the treatment of SI with esketamine was inconsistent. The pooled effect sizes for long-term anti-SI effects did not reveal significant differences between therapies. Our study indicated the efficacy of racemic ketamine monotherapy for rapidly and transiently reducing SI in individuals with uni- or bipolar depression, but the efficacy of racemic ketamine monotherapy against long-term suicidal ideation remains unclear. There is not -sufficient evidence to support the anti-suicidal effects of esketamine monotherapy.Protocol registration: Prospero registration number: CRD42023434380.

Keywords: Bipolar disorder; Esketamine; Ketamine; Major depressive disorder; Meta-analysis; Suicidal ideation; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no conflict of interest.

Similar articles

References

    1. organization WH (2021) Suicide. https://www.who.int/news-room/fact-sheets/detail/ suicide
    1. Miola A, Dal Porto V, Tadmor T et al (2021) Increased c-reactive protein concentration and suicidal behavior in people with psychiatric disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 144:537–552. https://doi.org/10.1111/acps.13351 - DOI - PubMed - PMC
    1. Su MH, Chen HC, Lu ML et al (2018) Risk profiles of personality traits for suicidality among mood disorder patients and community controls. Acta Psychiatr Scand 137:30–38. https://doi.org/10.1111/acps.12834 - DOI - PubMed
    1. Li X, Mu F, Liu D et al (2022) Predictors of suicidal ideation, suicide attempt and suicide death among people with major depressive disorder: a systematic review and meta-analysis of cohort studies. J Affect Disord 302:332–351. https://doi.org/10.1016/j.jad.2022.01.103 - DOI - PubMed
    1. Paljärvi T, Tiihonen J, Lähteenvuo M et al (2023) Psychotic depression and deaths due to suicide. J Affect Disord 321:28–32. https://doi.org/10.1016/j.jad.2022.10.035 - DOI - PubMed

MeSH terms